Современные представления о роли пробиотиков в профилактике и лечении различных заболеваний: фокус на Линекс


Цитировать

Полный текст

Аннотация

Аннотация. В статье представлены доказательные данные о роли пробиотиков в терапии различных заболеваний и рекомендации по их применению. На основании результатов клинических исследований обсуждается эффективность и безопасность комбинированного пробиотика Линекс.

Полный текст

Современные представления о роли пробиотиков в профилактике и лечении различных заболеваний: фокус на Линекс. - Аннотация. В статье представлены доказательные данные о роли пробиотиков в терапии различных заболеваний и рекомендации по их применению. На основании результатов клинических исследований обсуждается эффективность и безопасность комбинированного пробиотика Линекс.
×

Об авторах

Е А Ушкалова

РУДН, Москва

Email: eushk@yandex.ru

Список литературы

  1. Парфенов А.И., Бондаренко В.М. Что нам дал вековой опыт познания симбионтной кишечной микрофлоры. Тер арх 2012; 2: 5-10.
  2. Prakash S., Rodes L., Coussa-Charley M., Tomaro-Duchesneau C. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 2011; 5: 71-86.
  3. Floch M.H., Walker W.A., Madsen K. et al. Recommendations for probiotic use-2011 update. J Clin Gastroenterol 2011; 45: 168-171.
  4. World Gastroenterology Organisation Practice Guideline. Probiotics and prebiotics May 2008.
  5. Wang Z.H., Gao Q.Y., Fang J.Y. Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy. J Clin Gastroenterol 2013; 47 (1): 25-32.
  6. Zheng X., Lyu L., Mei Z. Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate: Evidence from a meta-analysis. Rev Esp Enferm Dig 2013; 105 (8): 445-453.
  7. Zou J., Dong J., Yu X. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter. 2009; 14 (5): 97-107.
  8. Li S., Huang X.L., Sui J.Z. et al. Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children. Eur J Pediatr 2014; 173 (2): 153-161.
  9. Хавкин А.И., Блат С.Ф. Роль пробиотической терапии при инфекции Helicobacter pylori у детей. Детские инфекции 2008; 4: 53-58.
  10. Хавкин А.И., Жихарева Н.С. Терапия антибиотик-ассоциированного дисбактериоза. Рус мед журн 2006; 19: 12.
  11. Deshpande G., Rao S., Patole S. et al. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010; 125: 921-930.
  12. Wang Q., Dong J., Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg 2012; 47 (1): 241-248.
  13. Alfaleh K., Anabrees J., Bassler D., Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011; 3: CD005496.
  14. Bernardo W.M., Aires F.T., Carneiro R.M. et al. Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: a systematic review and meta-analysis. J Pediatr (Rio J) 2013; 89 (1): 18-24.
  15. Deshpande G.C., Rao S.C., Keil A.D., Patole S.K. Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med 2011; 9: 92.
  16. Downard C.D., Renaud E., St Peter S.D. et al. Treatment of necrotizing enterocolitis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg 2012; 47 (11): 2111-2222.
  17. Salminen S., Nybom S., Meriluoto J. et al. Interaction of probiotics and pathogens - benefits to human health? Curr Opin Biotechnol 2010; 21: 157-167.
  18. Сухорукова М.В., Тимохова А.В., Эйдельштейн М.В., Козлов Р.С. Чувствительность к антибиотикам штаммов бактерий, входящих в состав пробиотика "Линекс". Клин микробиол антимикроб химиотер 2012; 3: 245-251.
  19. Anabrees J., Indrio F., Paes B., Alfaleh K. Probiotics for infantile colic: a systematic review. BMC Pediatr 2013; 13 (1): 186.
  20. McFarland L.V., Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008; 17: 2650-2661.
  21. Hoveyda N., Heneghan C., Mahtani K.R. et al. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 2009; 9: 15.
  22. Moayyedi P., Ford A.C., Talley N.J. et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59 (3): 325-332.
  23. Ortiz-Lucas M., Tobhas A., Saz P. et al. Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis. Rev Esp Enferm Dig 2013; 105 (1): 19-36.
  24. Nikfar S., Rahimi R., Rahimi F. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum 2008; 51 (12): 1775-1780.
  25. Парфенов А.И., Ручкина И.Н., Атауллаханов Р.И. Постинфекционные синдром раздраженного кишечника. Особенности патогенеза, диагностики и лечения. Рус мед журн 2010; 11: 2.
  26. Ford A., Vandvik P. Irritable bowel syndrome. Clin Evid (Online) 2012; 2012: pii: 0410.
  27. Simrén M., Barbara G., Flint H.J. et al. Intestinal microbiota in functional bowel disorders: a report. Gut 2013; 62 (1): 159-176.
  28. Scaldaferri F., Gerardi V., Lopetuso L.R. et al. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int 2013; 2013: 435268.
  29. Chapman T., Plosker G., Figgitt D. VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases. Drugs 2006; 66 (10): 1371-1387.
  30. Shen J., Zuo Z.X., Mao A.P. Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohn’s Disease, and Pouchitis: Meta-analysis of Randomized Controlled Trials. Inflamm Bowel Dis 2014; 20 (1): 21-35.
  31. Müllner K., Miheller P., Herszényi L., Tulassay Z. Probiotics in the Management of Crohn’s Disease and Ulcerative Colitis. Curr Pharm Des 2013 Oct 14. [Epub ahead of print].
  32. Bonis P., LaMont J., Rutgeerts P. et al. Approach to the adult with chronic diarrhea in developed countries. Uptodate June 2011. http://www.uptodate.com/contents/approach-to-the-adult-with-chronic-diarrhea-in-developed-countries?source=see_link4
  33. Wasilewska E., Złotkowska D., Pijagin M.E. The role of intestinal microflora and probiotic bacteria in prophylactic and development of colorectal cancer. Postepy Hig Med Dosw (Online). 2013; 67: 837-847.
  34. Uccello M., Malaguarnera G., Basile F. et al. Potential role of probiotics on colorectal cancer prevention. BMC Surg 2012; 12 Suppl 1: S35.
  35. Wilt T.J., Shaukat A., Shamliyan T. et al. Lactose intolerance and health. Evid Rep Technol Assess (Full Rep) 2010; 192: 1-410.
  36. Shaukat A., Levitt M.D., Taylor B.C. et al. Systematic review: effective management strategies for lactose intolerance. Ann Intern Med 2010; 152 (12): 797-803.
  37. Henao-Mejia J., Elinav E., Thaiss C.A. et al. Role of the intestinal microbiome in liver disease. J Autoimmun 2013; 46: 66-73.
  38. Jover-Cobos M., Khetan V., Jalan R. Treatment of hyperammonemia in liver failure. Curr Opin Clin Nutr Metab Care 2014; 17 (1): 105-110.
  39. McGee R.G., Bakens A., Wiley K. et al. Probiotics for patients with hepatic encephalopathy. Cochrane Database Syst Rev 2011; 11: CD008716.
  40. Mohammad R.A., Regal R.E., Alaniz C. Combination therapy for the treatment and prevention of hepatic encephalopathy. Ann Pharmacother 2012; 46 (11): 1559-1563.
  41. Younossi Z.M., Reyes M.J., Mishra A. et al. Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. Aliment Pharmacol Ther 2014; 39 (1): 3-14.
  42. Kelishadi R., Farajian S., Mirlohi M. Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidences. Hepat Mon 2013 Apr 9;13(4):e7233
  43. Ma Y.Y., Li L., Yu C.H. et al. Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis. World J Gastroenterol 2013; 19 (40): 6911-6918.
  44. Wang Y., Liu Y., Kirpich I. Lactobacillus rhamnosus GG reduces hepatic TNF? production and inflammation in chronic alcohol-induced liver injury. J Nutr Biochem 2013; 24 (9): 1609-1615.
  45. Wang Y., Kirpich I., Liu Y. et al. Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am J Pathol 2011; 179 (6): 2866-2875.
  46. Селиверстов П., Радченко В., Сафроненкова И., Ситкин С. Взаимоотношения печени и кишечника на фоне дисбаланса микрофлоры толстой кишки. Врач 2009; 10: 12.
  47. Kim N.Y., Ji G.E. Effects of probiotics on the prevention of atopic dermatitis. Korean J Pediatr 2012; 55 (6): 193-201.
  48. Lee J., Seto D., Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008; 121 (1): 116-121.
  49. Foolad N., Brezinski E.A., Chase E.P., Armstrong A.W. Effect of nutrient supplementation on atopic dermatitis in children: a systematic review of probiotics, prebiotics, formula, and fatty acids. JAMA Dermatol 2013; 149 (3): 350-355.
  50. Elazab N., Mendy A., Gasana J. et al. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics 2013; 132 (3): e666-676.
  51. Tang L.J., Chen J., Shen Y. [Meta-analysis of probiotics preventing allergic diseases in infants]. Zhonghua Er Ke Za Zhi 2012; 50 (7): 504-509.
  52. Dang D., Zhou W., Lun Z.J. et al. Meta-analysis of probiotics and/or prebiotics for the prevention of eczema. J Int Med Res 2013; 41 (5): 1426-1436.
  53. Das R.R., Naik S.S., Singh M. Probiotics as additives on therapy in allergic airway diseases: a systematic review of benefits and risks. Biomed Res Int 2013; 2013: 231979.
  54. Усенко Д.В. Острые кишечные инфекции у детей с атопическим дерматитом: клинико-иммунологические особенности, тактика терапии и иммунореабилитации: Автореф. дис. ... д-ра мед. наук. М 2013; 44.
  55. Foisy M., Boyle R.J., Chalmers J.R. et al. The prevention of eczema in infants and children: an overview of Cochrane and non-Cochrane reviews. Evid Based Child Health 2011; 6 (5): 1322-1339.
  56. Hao Q., Lu Z., Dong B.R. et al. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2011 9: CD006895.
  57. Kang E.J., Kim S.Y., Hwang I.H., Ji Y.J. The effect of probiotics on prevention of common cold: a meta-analysis of randomized controlled trial studies. Korean J Fam Med 2013; 34 (1): 2-10.
  58. Petrof E.O., Dhaliwal R., Manzanares W. et al. Probiotics in the critically ill: a systematic review of the randomized trial evidence. Crit Care Med 2012; 40 (12): 3290-3302.
  59. Liu K.X., Zhu Y.G., Zhang J. et al. Probiotics’ effects on the incidence of nosocomial pneumonia in critically ill patients: a systematic review and meta-analysis. Crit Care 2012; 16 (3): R10.
  60. Barraud D., Bollaert P.E., Gibot S. Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials. Chest 2013; 143 (3): 646-655.
  61. Kinross J.M., Markar S., Karthikesalingam A. et al. A meta-analysis of probiotic and synbiotic use in elective surgery: does nutrition modulation of the gut microbiome improve clinical outcome? JPEN J Parenter Enteral Nutr 2013; 37 (2): 243-253.
  62. Pitsouni E., Alexiou V., Saridakis V. et al. Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Clinharmacol 2009; 65 (6): 561-570.
  63. Grin P.M., Kowalewska P.M., Alhazzan W. et al. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Can J Urol 2013; 20 (1): 6607-6614.
  64. Sekar U., Shanthi M. Blastocystis: Consensus of treatment and controversies. Trop Parasitol 2013; 3 (1): 35-39.
  65. Dinleyici E.C., Eren M., Dogan N. et al. Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystishominis infection. Parasitol Res 2011; 108 (3): 541-545.
  66. Besirbellioglu B.A., Ulcay A., Can M. et al. Saccharomyces boulardii and infection due to Giardia lamblia. Scand J Infect Dis 2006; 38 (6-7): 479-481.
  67. Корниенко Е.А. Современные диагностика и лечение лямблиоза у детей. Consilium medicum 2010; 1: 25.
  68. Сигидаев А.С. Клинико-лабораторная характеристика бластоцистной инвазии у больных HCV-инфекцией: Автореф. дис. … канд. мед. наук. СПб 2012; 17.
  69. Firouzi S., Barakatun-Nisak M.Y., Ismail A. et al. Role of probiotics in modulating glucose homeostasis: evidence from animal and human studies. Int J Food Sci Nutr 2013; 64 (6): 780-786.
  70. Lindsay K.L., Walsh C.A., Brennan L., McAuliffe F.M. Probiotics in pregnancy and maternal outcomes: a systematic review. J Matern Fetal Neonatal Med 2013; 26 (8): 772-778.
  71. Vandevusse L., Hanson L., Safdar N. Perinatal outcomes of prenatal probiotic and prebiotic administration: an integrative review. J Perinat Neonatal Nurs 2013; 27 (4): 288-301.
  72. Luoto R., Kalliomaki M., Laitinen K., Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes 2010; 16: on line.
  73. Million M., Angelakis E., Paul M. et al. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog 2012; 53 (2): 100-108.
  74. Sanaie S., Ebrahimi-Mameghani M., Mahmoodpoor A. et al. Effect of a Probiotic Preparation (VSL#3) on Cardiovascular Risk Parameters in Critically-Ill Patients. J Cardiovasc Thorac Res 2013; 5 (2): 67-70.
  75. Rossi M., Klein K., Johnson D.W., Campbell K.L. Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis. Int J Nephrol 2012; 2012: 673631.
  76. Cagetti M.G., Mastroberardino S., Milia E. et al. The use of probiotic strains in caries prevention: a systematic review. Nutrients 2013; 5 (7): 2530-2550.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО "Консилиум Медикум", 2014

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Адрес издателя

  • 127055, г. Москва, Алабяна ул., 13, корп.1

Адрес редакции

  • 127055, г. Москва, Алабяна ул., 13, корп.1

По вопросам публикаций

  • +7 (926) 905-41-26
  • editor@ter-arkhiv.ru

По вопросам рекламы

  • +7 (495) 098-03-59

 

  


Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах